Showing results (1681-1690 of 1,743) with videos related to

Sort By:
Pageof 175
Radiology|May 28, 2024
Effects of Low-Level Light Therapy on Resting-State Connectivity Following Moderate Traumatic Brain Injury: Secondary Analyses of a Double-blinded Placebo-controlled StudySuk-Tak Chan, Nathaniel Mercaldo, Maria G Figueiro Longo, et al.
Lancet (London, England)|July 31, 2007
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trialD Catovsky, S Richards, E Matutes, et al.
Photobiomodulation, Photomedicine, and Laser Surgery|June 28, 2024
Photobiomodulation Treatment with a Home-Use Device for COVID-19: A Randomized Controlled Trial for Efficacy and SafetyLew Lim, Nazanin Hosseinkhah, Mark Van Buskirk, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 14, 2023
Graphene oxide nanoarchitectures in cancer biology: Nano-modulators of autophagy and apoptosisAfshin Taheriazam, Ghazaleh Gholamiyan Yousef Abad, Shima Hajimazdarany, et al.
JAMA|May 26, 2018
Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical TrialGanesh Raghu, Bernt van den Blink, Mark J Hamblin, et al.
Cancer Research|May 14, 2009
Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein responseAngelika Szokalska, Marcin Makowski, Dominika Nowis, et al.
JAMA Network Open|September 14, 2020
Effect of Transcranial Low-Level Light Therapy vs Sham Therapy Among Patients With Moderate Traumatic Brain Injury: A Randomized Clinical TrialMaria Gabriela Figueiro Longo, Can Ozan Tan, Suk-Tak Chan, et al.
American Journal of Respiratory and Critical Care Medicine|June 30, 2022
A Phase IIb Randomized Clinical Study of an Anti-αvβ6 Monoclonal Antibody in Idiopathic Pulmonary FibrosisGanesh Raghu, Majd Mouded, Daniel C Chambers, et al.
Blood|February 22, 2003
ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profileAdrian Wiestner, Andreas Rosenwald, Todd S Barry, et al.
The Lancet. Respiratory Medicine|May 25, 2019
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension studyGanesh Raghu, Bernt van den Blink, Mark J Hamblin, et al.
Pageof 175